An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension
2019 · Diabetologia · 33 citations
https://doi.org/10.1007/s00125-019-05062-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
887
Citations
15
h-index
17
i10-index
James Wakefield is an academic researcher from Cyclerion (United States). The author has contributed to research in topics: Nitric Oxide and Endothelin Effects & Phosphodiesterase function and regulation & Blood Pressure and Hypertension Studies. The author has an h-index of 15, co-authored 30 publications.
Click to start Chat